Effect of repetitive trans-spinal magnetic stimulation on Parkinson disease

Effect of repetitive trans-spinal magnetic stimulation on Parkinson disease - Effect of rTSMS on Parkinson disease

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014159

Enrollment

Registered

2014-06-05

Start date

2014-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson disease

Interventions

Patients were allocated to rTSMS group. PD patients were treated with rTSMS (a train of 40 stimuli) twice a week for 4 weeks. Patients were allocated to sham group. PD patients were treated with sham

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Eligibility criteria included a clinical diagnosis of PD with a disease severity rating of stage 3 to 4 on the Hoehn and Yahr scale,stable medication use, medical clearance for participation, and willingness to participate in treatment and outcome testing.

Exclusion criteria

Exclusion criteria: Exclusion criteria were current participation in any other behavioral or pharmacologic study or debilitating conditions that would impede full participation.

Design outcomes

Primary

Measure	Time frame
UPDRS	—

Secondary

Measure	Time frame
Walking time, TUG, FAB, MMSE, Thoracolumber spine flexion angle	—

Countries

Japan

Contacts

Public ContactSayaka Miyake

Tokushima National Hospital, National Hospital Organization Department of Clinical Research

rinsyou@tokushima.-nh.hosp.go.jp0883-24-2161

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026